Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-20

Clinical Trial Update: Initial Screening of Gemfibrozil as a Novel Treatment for Tobacco Addiction [Phase 2]

View source ↗

Summary

Phase 2 screening study evaluating gemfibrozil as a treatment for nicotine dependence has completed, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gemfibrozil (Gemfibrozil)

Snippet

Sponsor: Centre for Addiction and Mental Health | Conditions: Nicotine Dependence | Phase 2 | Status: COMPLETED | Results posted: 2017-04-20